you are here: Home News Emcure Pharma

Emcure Pharma

Emcure Pharma jumps 3% to fresh 52-week high amid weight-loss injection boost: Analyst says buy on dips
Emcure Pharma shares rise 2% on deal to distribute Sanofi India's oral anti-diabetic products
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
Emcure Pharmaceuticals block deal: Shares worth Rs 574 crore changed hands, Bain Capital likely seller
Emcure Pharma Q3 Results: Net profit rises 35% to Rs 154 crore
Gainers & Losers: Stocks that moved the most on November 26
Emcure Pharmaceuticals stock rises 10% as Kotak upgrades to 'add', sees 28% upside
Emcure Pharma share surge 6% after healthy Q2 earnings show
Kotak initiates coverage on Emcure Pharma with 'add' rating, shares surge 5%
Jefferies adds Emcure Pharma, IndiGo in model portfolio; HDFC Bank weightage rises
Namita Thapar's Emcure Pharma stock rises 5% as Jefferies initiates coverage with 'Buy' rating
Brokerage Radar: Apollo Hospitals gets a downgrade; Bansal Wire, Emcure Pharma get 'buy' tags
Emcure Pharma may make strong debut with 33-36% premium on July 10
Emcure Pharma IPO day 3: Issue subscribed 38x so far, QIBs roar
Emcure Pharma IPO day 2: Issue oversubscribed at 3.6x led by NIIs, retail investors
IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week
Sanofi ties up with Emcure to broaden reach of cardiovascular brands
Glenmark arm, Emcure, 3 other pharma companies line up Rs 7,000 crore IPOs
Exclusive | Bain Capital-backed Emcure Pharma to dial D-Street after demerger
Sun Pharma, Ranbaxy rise 2% post completion of merger
Sun-Ranbaxy USD 4 billion merger completed
Sun Pharma, Ranbaxy up 2% on final CCI nod for merger deal
Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands
Differential pricing of drugs a hit with pharma cos

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Emcure Pharma

Emcure Pharma jumps 3% to fresh 52-week high amid weight-loss injection boost: Analyst says buy on dips

Emcure Pharma shares rise 2% on deal to distribute Sanofi India's oral anti-diabetic products

Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India

Emcure Pharmaceuticals block deal: Shares worth Rs 574 crore changed hands, Bain Capital likely seller

Emcure Pharma Q3 Results: Net profit rises 35% to Rs 154 crore

Gainers & Losers: Stocks that moved the most on November 26

Emcure Pharmaceuticals stock rises 10% as Kotak upgrades to 'add', sees 28% upside

Emcure Pharma share surge 6% after healthy Q2 earnings show

Kotak initiates coverage on Emcure Pharma with 'add' rating, shares surge 5%

Jefferies adds Emcure Pharma, IndiGo in model portfolio; HDFC Bank weightage rises

Namita Thapar's Emcure Pharma stock rises 5% as Jefferies initiates coverage with 'Buy' rating

Brokerage Radar: Apollo Hospitals gets a downgrade; Bansal Wire, Emcure Pharma get 'buy' tags

Emcure Pharma may make strong debut with 33-36% premium on July 10

Emcure Pharma IPO day 3: Issue subscribed 38x so far, QIBs roar

Emcure Pharma IPO day 2: Issue oversubscribed at 3.6x led by NIIs, retail investors

IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week

Sanofi ties up with Emcure to broaden reach of cardiovascular brands

Glenmark arm, Emcure, 3 other pharma companies line up Rs 7,000 crore IPOs

Exclusive | Bain Capital-backed Emcure Pharma to dial D-Street after demerger

Sun Pharma, Ranbaxy rise 2% post completion of merger

Sun-Ranbaxy USD 4 billion merger completed

Sun Pharma, Ranbaxy up 2% on final CCI nod for merger deal

Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands

Differential pricing of drugs a hit with pharma cos